메뉴 건너뛰기




Volumn 13, Issue 7, 2013, Pages 1085-1092

Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia

Author keywords

Anti D; Idiopathic thrombocytopaenia; Rozrolimupab

Indexed keywords

AZATHIOPRINE; BILIRUBIN; CYCLOPHOSPHAMIDE; ERYTHROCYTE ANTIGEN; FC RECEPTOR; FIBRINOGEN; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISOLONE; RHESUS D ANTIBODY; RITUXIMAB; ROZROLIMUPAB;

EID: 84878926472     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.800856     Document Type: Article
Times cited : (5)

References (35)
  • 1
    • 38349190476 scopus 로고    scopus 로고
    • Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management
    • Stasi R, Evangelista ML, Stipa E, et al. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 2008;99:4-13
    • (2008) Thromb Haemost , vol.99 , pp. 4-13
    • Stasi, R.1    Evangelista, M.L.2    Stipa, E.3
  • 2
    • 1642546472 scopus 로고    scopus 로고
    • Management of immune thrombocytopenic purpura in adults
    • Stasi R, Proven D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 2004;79:504-22
    • (2004) Mayo Clin Proc , vol.79 , pp. 504-522
    • Stasi, R.1    Proven, D.2
  • 3
    • 0033179664 scopus 로고    scopus 로고
    • The incidence of idiopathic thrombocytopenic purpura in adults increases with age
    • Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999;94:909-13
    • (1999) Blood , vol.94 , pp. 909-913
    • Frederiksen, H.1    Schmidt, K.2
  • 4
    • 0141763618 scopus 로고    scopus 로고
    • Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: A prospective study of a population-based cohort of 245 patients
    • Neylon AJ, Saunders PW, Howard MR, et al. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003;122:966-74
    • (2003) Br J Haematol , vol.122 , pp. 966-974
    • Neylon, A.J.1    Saunders, P.W.2    Howard, M.R.3
  • 5
    • 33645356971 scopus 로고    scopus 로고
    • Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia
    • Stasi R, Amadori S, Osborn J, et al. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia. PLoS Med 2006;3:e24
    • (2006) PLoS Med , vol.3
    • Stasi, R.1    Amadori, S.2    Osborn, J.3
  • 6
    • 0034641010 scopus 로고    scopus 로고
    • The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts
    • Cohen YC, Djulbegovic B, Shamai-Lubovitz O, et al. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Int Med 2000;160:1630-8
    • (2000) Arch Int Med , vol.160 , pp. 1630-1638
    • Cohen, Y.C.1    Djulbegovic, B.2    Shamai-Lubovitz, O.3
  • 7
    • 69249240344 scopus 로고    scopus 로고
    • The ITP syndrome: Pathogenic and clinical diversity
    • Cines DB, Bussel JB, Liebman HA, et al. The ITP syndrome: pathogenic and clinical diversity. Blood 2009;113:6511-21
    • (2009) Blood , vol.113 , pp. 6511-6521
    • Cines, D.B.1    Bussel, J.B.2    Liebman, H.A.3
  • 8
    • 34648836081 scopus 로고    scopus 로고
    • Definition, diagnosis and treatment of immune thrombocytopenic purpura in adults
    • George JN. Definition, diagnosis and treatment of immune thrombocytopenic purpura in adults. Curr Opin Haematol 2007;14:535-56
    • (2007) Curr Opin Haematol , vol.14 , pp. 535-556
    • George, J.N.1
  • 9
    • 23944470406 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(D) immune globulin intravenous administration for immune thrombocytopenic purpura
    • Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005;106:1532-7
    • (2005) Blood , vol.106 , pp. 1532-1537
    • Gaines, A.R.1
  • 10
    • 84868570501 scopus 로고    scopus 로고
    • Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia
    • Robak T, Windyga J, Trelinski J, et al. Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia. Blood 2012;120:3670-6
    • (2012) Blood , vol.120 , pp. 3670-3676
    • Robak, T.1    Windyga, J.2    Trelinski, J.3
  • 12
    • 0037410194 scopus 로고    scopus 로고
    • Mechanism of action of IVIG and anti-D in ITP
    • Lazarus AH, Crow AR. Mechanism of action of IVIG and anti-D in ITP. Transfus Apher Sci 2003;28:249-55
    • (2003) Transfus Apher Sci , vol.28 , pp. 249-255
    • Lazarus, A.H.1    Crow, A.R.2
  • 13
    • 0037410194 scopus 로고    scopus 로고
    • Mechanism of action of IVIG and anti-D in ITP
    • Lazarus AH, Crow AR. Mechanism of action of IVIG and anti-D in ITP. Transfus Apher Sci 2003;28:249-55
    • (2003) Transfus Apher Sci , vol.28 , pp. 249-255
    • Lazarus, A.H.1    Crow, A.R.2
  • 14
    • 0018097191 scopus 로고
    • Effect of corticosteroid therapy on the phagocytosis of antibody-coated platelets by human leukocytes
    • Handin RI, Stossel TP. Effect of corticosteroid therapy on the phagocytosis of antibody-coated platelets by human leukocytes. Blood 1978;51:771-9
    • (1978) Blood , vol.51 , pp. 771-779
    • Handin, R.I.1    Stossel, T.P.2
  • 15
    • 84864542296 scopus 로고    scopus 로고
    • High dose dexamethasone vs. conventional dose prednisolone in adults with immune thrombocytopenia: A prospective multicenter phase II trial. Amer soc of haem congress [abstract]
    • abstract 3687
    • Bae SH, Ryoo HM, Lee W, et al. High dose dexamethasone vs. conventional dose prednisolone in adults with immune thrombocytopenia: a prospective multicenter phase II trial. Amer Soc of Haem Congress [abstract]. Blood 2010;116:abstract 3687
    • (2010) Blood , pp. 116
    • Bae, S.H.1    Ryoo, H.M.2    Lee, W.3
  • 16
    • 33747495173 scopus 로고    scopus 로고
    • Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura
    • Balagué C, Vela S, Targarona EM, et al. Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura. Surg Endosc 2006;20:1208-13
    • (2006) Surg Endosc , vol.20 , pp. 1208-1213
    • Balagué, C.1    Vela, S.2    Targarona, E.M.3
  • 17
    • 12244303642 scopus 로고    scopus 로고
    • Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)
    • Schwartz J, Leber MD, Gilli S, et al. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 2003;72:94-8
    • (2003) Am J Hematol , vol.72 , pp. 94-98
    • Schwartz, J.1    Leber, M.D.2    Gilli, S.3
  • 18
    • 13244257208 scopus 로고    scopus 로고
    • Efficacy and safety of splenectomy in immune thrombocytopenic purpura: Long-term results of 402 cases
    • Vianelli N, Galli M, de Vivo A, et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 2005;90:72-7
    • (2005) Haematologica , vol.90 , pp. 72-77
    • Vianelli, N.1    Galli, M.2    De Vivo, A.3
  • 19
    • 70449468812 scopus 로고    scopus 로고
    • Vascular complications after splenectomy for haematological disorders
    • Crary S, Buchanan GR. Vascular complications after splenectomy for haematological disorders. Blood 2009;114:2861-8
    • (2009) Blood , vol.114 , pp. 2861-2868
    • Crary, S.1    Buchanan, G.R.2
  • 20
    • 84864555317 scopus 로고    scopus 로고
    • How i treat immune thrombocytopenia: The choice between splenectomy or a medical therapy as a second line treatment
    • Ghanima W, Godeau B, Cines DB, et al. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second line treatment. Blood 2012;120:960-9
    • (2012) Blood , vol.120 , pp. 960-969
    • Ghanima, W.1    Godeau, B.2    Cines, D.B.3
  • 21
    • 2042544763 scopus 로고    scopus 로고
    • The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
    • Cooper N, Stasi R, Cunningham-Rundles S, et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 2004;125:232-9
    • (2004) Br J Haematol , vol.125 , pp. 232-239
    • Cooper, N.1    Stasi, R.2    Cunningham-Rundles, S.3
  • 22
    • 38649120593 scopus 로고    scopus 로고
    • Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial
    • Kuter D, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008;371:395-403
    • (2008) Lancet , vol.371 , pp. 395-403
    • Kuter, D.1    Bussel, J.B.2    Lyons, R.M.3
  • 23
    • 84856739696 scopus 로고    scopus 로고
    • Sustained hemostatic platelet counts in adult patients with primary immune thrombocytopenia (ITP) following cessation of romiplostim: Four European case studies (abstract 0237)
    • Newland A, Cervinek L, Eggermann J, et al. Sustained hemostatic platelet counts in adult patients with primary immune thrombocytopenia (ITP) following cessation of romiplostim: four European case studies (abstract 0237). Haemtologica 2010;96:98
    • (2010) Haemtologica , vol.96 , pp. 98
    • Newland, A.1    Cervinek, L.2    Eggermann, J.3
  • 24
    • 79952924019 scopus 로고    scopus 로고
    • Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura
    • Stasi R. Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura. Curr Opin Mol Ther 2010;12:734-40
    • (2010) Curr Opin Mol Ther , vol.12 , pp. 734-740
    • Stasi, R.1
  • 25
    • 65349094579 scopus 로고    scopus 로고
    • Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
    • Cheung E, Liebman HA. Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia. Biologics 2009;3:57-62
    • (2009) Biologics , vol.3 , pp. 57-62
    • Cheung, E.1    Liebman, H.A.2
  • 26
    • 0025772328 scopus 로고
    • Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect
    • Bussel JB, Graziano JN, Kimberly RP, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood 1991;77:1884-93
    • (1991) Blood , vol.77 , pp. 1884-1893
    • Bussel, J.B.1    Graziano, J.N.2    Kimberly, R.P.3
  • 27
    • 51349161357 scopus 로고    scopus 로고
    • Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn
    • Kumpel BM. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. Clin Exp Immunol 2008;154:1-5
    • (2008) Clin Exp Immunol , vol.154 , pp. 1-5
    • Kumpel, B.M.1
  • 28
    • 84894017872 scopus 로고    scopus 로고
    • Intravenous anti-D treatment in immune thrombocytopenic purpura: A randomised, double blind, placebo-controlled trial
    • Scaradavou A, Woo B, Woloski BM, et al. Intravenous anti-D treatment in immune thrombocytopenic purpura: a randomised, double blind, placebo-controlled trial. Lancet 2009;373:641-8
    • (2009) Lancet , vol.373 , pp. 641-648
    • Scaradavou, A.1    Woo, B.2    Woloski, B.M.3
  • 29
    • 0141889306 scopus 로고    scopus 로고
    • Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-a receptor antagonist
    • Coopamah MD, Freedman J, Semple JW. Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-a receptor antagonist. Blood 2003;102:2862-7
    • (2003) Blood , vol.102 , pp. 2862-2867
    • Coopamah, M.D.1    Freedman, J.2    Semple, J.W.3
  • 30
    • 0034656023 scopus 로고    scopus 로고
    • Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
    • Gaines AR. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000;95:2523-9
    • (2000) Blood , vol.95 , pp. 2523-2529
    • Gaines, A.R.1
  • 31
    • 65349094579 scopus 로고    scopus 로고
    • Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
    • Cheung E, Liebman HA. Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia. Biologics 2009;3:57-62
    • (2009) Biologics , vol.3 , pp. 57-62
    • Cheung, E.1    Liebman, H.A.2
  • 32
    • 40449102205 scopus 로고    scopus 로고
    • A human anti-D monoclonal antibody selected for enhanced FccRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies
    • Beliard R, Waegemans T, Notelet D, et al. A human anti-D monoclonal antibody selected for enhanced FccRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies. Br J Haematol 2008;41:109-19
    • (2008) Br J Haematol , vol.41 , pp. 109-119
    • Beliard, R.1    Waegemans, T.2    Notelet, D.3
  • 33
    • 21044436632 scopus 로고    scopus 로고
    • Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications, and information resources
    • Neil S, Lipman LR, Jackson LJ, et al. Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. ILAR J 2005;46(3):258-68
    • (2005) ILAR J , vol.46 , Issue.3 , pp. 258-268
    • Neil, S.1    Lipman, L.R.2    Jackson, L.J.3
  • 34
    • 84866621708 scopus 로고    scopus 로고
    • Impact on N-glycosylation profile of monoclonal anti-D antibodies as a way to control their immunoregulatory and cytotoxic properties
    • Olovnikova NI, Ershler MA, Grigorieva OV, et al. Impact on N-glycosylation profile of monoclonal anti-D antibodies as a way to control their immunoregulatory and cytotoxic properties. Biochemistry (Moscow) 2012;77:925-33
    • (2012) Biochemistry (Moscow) , vol.77 , pp. 925-933
    • Olovnikova, N.I.1    Ershler, M.A.2    Grigorieva, O.V.3
  • 35
    • 0030900678 scopus 로고    scopus 로고
    • Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients
    • Scaradavou A, Woo B, Woloski BMR, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997;89:2689-700
    • (1997) Blood , vol.89 , pp. 2689-2700
    • Scaradavou, A.1    Woo, B.2    Woloski, B.M.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.